Skip to content

Search

Showing results for "clinical trials"

Dose-Banding of Intravenous Piperacillin-Tazobactam in Pediatric Surgical Inpatients

Dosing errors are the most commonly reported medication error in children. Dosing is often prescribed per weight or based on body area.

Where were those rabbits? A new paradigm to determine cerebral lateralisation of visuospatial memory function in children

In the majority of people, functional differences are observed between the two cerebral hemispheres: language production is typically subserved by the left...

Fresh Science to target painful ear infections

The Kids's Dr Ruth Thornton is one of 12 finalists in the annual national Fresh Science competition with her research into middle-ear infections.

Past research

Find out about many of our previous research studies and trials, and those that are ongoing but are no longer recruiting participants.

Stan Perron Charitable Foundation grants back ambitious research projects

Eleven researchers from The Kids Research Institute Australia will benefit from the latest round of Stan Perron Charitable Foundation Research Fellowship and Platform grants, with two researchers receiving prestigious Perron Platform grants and a further ten awarded Research Fellowships.

$3.4mill to improve treatment management of cystic fibrosis

The Kids researchers have been awarded over $3.4 million for a new trial to pioneer improved ways for managing cystic fibrosis (‘CF’).

Acellular Pertussis Vaccine Given in the Week After Birth Does Not Impair Antibody Responses to Later Childhood Doses

A birth acellular pertussis vaccine may be a valuable alternative for immunity against infant pertussis when a pregnancy pertussis vaccine has not been administered. We assessed whether a birth dose may impair immunoglobulin G (IgG) responses to childhood pertussis boosters.

Immunogenicity and Safety of a 2 + 1 DTPa Priming Schedule in Australian Infants and the Impact of Maternally Derived Antibodies on Pertussis Antibody Responses up to 4 Years of Age

We assessed the impact of maternally derived pertussis antibodies on infant responses to a 2 + 1 vaccine schedule (6 weeks, 12 weeks, and 12 months). Infants with baseline antibodies showed lower IgG responses following the primary vaccination series, but this did not impair booster responses at 4 years of age.

A role for early oral exposure to house dust mite allergens through breast milk in IgE-mediated food allergy susceptibility

This study highlights an unpredicted potential risk factor for the development of food allergy, that is, D pteronyssinus allergens in breast milk

Maternal Fiber Dietary Intakes during Pregnancy and Infant Allergic Disease

Maternal resistant starch consumption was differentially associated with infant phenotypes, with reduced risk of infant wheeze, but increased risk of eczema